

Bal Pharma Unit - 4, is a finished dosage facility for manufacturing Tablets, Capsules, Creams, Gels, and Ointments. The manufacturing plant is cGMP and EUGMP approved.
This facility has state-of-the-art infrastructure built as per EUGMP, UKMHRA, WHO-TRS, USFDA standards and is fully operational, equipped with ultra-modern machinery to cater to global healthcare needs.
| Annual Capacity |
| 1.80 billion Tablets 300 million Capsules 20 million Tubes |
The products are exported to South East Asia, Middle East, Latin America, and African markets. The plant also caters to contract manufacturing needs, both in India and abroad.
The manufacturing facility is approved by MCAZ Zimbabwe, PMPB Malawi, NDA Uganda, PPB Kenya, TFDA Tanzania, FMHACA Ethiopia, NAFDAC Nigeria, Republic of Yemen & Malta Medicines Authority (EUGMP), Malta.